A punctal plug drug delivery system was found to be safe and effective for reducing pain and inflammation associated with cataract surgery in a phase II FDA study.
Side effects of drugs are always concerns, no matter the age or general health of patients. Those concerns are amplified in older populations, particularly those at increased risk of cardiovascular events. How might this affect cataract patients?
Study authors proposed their pathway for managing patients taking antithrombotic drugs. For low-risk procedures—sub-Tenon/topical cataract, corneal, chalazion, eyelid cyst/lesion removal, and strabismus surgeries—antiplatelets can be continued.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
